“david-edwards” Archives

Entry Author Date Location
See Boston’s Newest Innovators & Influencers this Wed. at INFLUX 06/20/16 Boston
Startups: Get Free Tickets to Influx on June 22, Thanks to NEVCA 06/06/16 Boston
Saver Rate Ends Today for INFLUX—Grab Your Tickets Now 06/01/16 Boston
Agenda Live For Influx—Event Welcomes Boston’s Innovation Newcomers 05/26/16 Boston
Join GE, Watson Health, Akamai, and More at INFLUX on June 22 05/24/16 Boston
After Reinvention, Pulmatrix Wraps Up Ruthigen Deal, Heads to Nasdaq 06/16/15 Boston
WikiCell Whips Up $10M from Flagship and Polaris for Edible Food Packaging 09/04/12 Boston
Pulmatrix Names Clarke CEO, Releases Promising Data on Lung Drug 09/04/12 Boston
Harvard Experiment Fund, Backed by NEA, Joins Crowded Investor Field 01/31/12 Boston
The Bob Langer and Polaris Family Tree: From Acusphere to Momenta to Visterra 04/19/11 Boston
Pulmatrix Pulls in $5.7M DARPA Grant to Develop Drug Against Respiratory Threats 12/14/10 Boston
Pulmatrix Scores $30M To Block All Sorts of Bugs That Make People Sick in the Lungs 11/02/09 Boston
Pulmatrix, With One Drug for Multiple Bugs, Aims to Fundamentally Change Flu Treatment 06/09/09 Boston
First Inhalable TB Vaccine Being Prepped for Clinical Trials By Harvard, MEND Scientists 10/16/08 Boston
Sirtris Settles in at GSK, Alnylam Raises IP Questions on Bio Bill, Targanta Takes on Cubist’s Market, & More Life Sciences News 09/24/08 Boston
Pulmatrix, Emerging From Stealth Mode, Makes Aerosols to Kill Flu and Bacterial Bugs in the Lungs 09/18/08 Boston
Page 1 of 1